PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsClindamycin
Clindamycin
/ Clindamycin, Acanya, Cabtreo, Cleocin, Clindagel, Clindamycin, Clindamycin /, Clinderm, Clindesse, Clindets, Duac, Onexton, Veltin, Xaciato, Ziana (clindamycin) is a small molecule pharmaceutical. Clindamycin was first approved as Cleocin hydrochloride on 1982-01-01. It is used to treat acne vulgaris, actinomycetales infections, bacterial infections, bacterial vaginosis, and bacteroides infections amongst others in the USA.
Download report
Favorite
COVID-19
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
respiratory tract diseasesD012140
urogenital diseasesD000091642
skin and connective tissue diseasesD017437
Trade Name
FDA
EMA
Cleocin, Clindagel, Clindamycin, Clinderm, Clindesse, Clindets, Xaciato (discontinued: Cleocin, Clindamycin, Evoclin)
Combinations
Cabtreo, Clindamycin benzoyl peroxide, Clindamycin tretinoin, Duac, Onexton, Veltin, Ziana (discontinued: Benzaclin, Clindamycin benzoyl peroxide)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Clindamycin phosphate
Tradename
Company
Number
Date
Products
CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%APP PharmaceuticalsN-050635 RX1989-12-22
1 products, RLD, RS
CLINDAGELBausch Health CompaniesN-050782 RX2000-11-27
1 products, RLD, RS
CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDEBaxterN-208083 RX2017-04-20
3 products, RLD, RS
XACIATOOrganonN-215650 RX2021-12-07
1 products, RLD, RS
CLINDESSEPadagisN-050793 RX2004-11-30
1 products, RLD, RS
CLEOCIN PHOSPHATEPfizerN-050441 RX1982-01-01
1 products, RLD, RS
CLEOCIN TPfizerN-050600 RX1989-05-31
1 products, RLD, RS
CLEOCIN TPfizerN-050615 RX1987-01-07
1 products, RLD, RS
CLEOCINPfizerN-050680 RX1998-03-02
1 products, RLD, RS
CLEOCINPfizerN-050767 RX1999-08-13
1 products, RLD, RS
Show 7 discontinued
Clindamycin phosphate
+
Tretinoin
Tradename
Company
Number
Date
Products
VELTINAlmirallN-050803 RX2010-07-16
1 products, RLD, RS
ZIANABausch Health CompaniesN-050802 RX2006-11-07
1 products, RLD, RS
Benzoyl peroxide
+
Clindamycin phosphate
Tradename
Company
Number
Date
Products
ACANYABausch Health CompaniesN-050819 RX2008-10-23
1 products, RLD, RS
ONEXTONBausch Health CompaniesN-050819 RX2014-11-24
1 products, RLD, RS
DUACStiefel LaboratoriesN-050741 RX2002-08-26
1 products, RLD
Show 1 discontinued
Clindamycin hydrochloride
Tradename
Company
Number
Date
Products
CLEOCIN HYDROCHLORIDEPfizerN-050162 RX1982-01-01
3 products, RLD
Adapalene
+
Benzoyl peroxide
+
Clindamycin phosphate
Tradename
Company
Number
Date
Products
CABTREOBausch Health CompaniesN-216632 RX2023-10-20
1 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
acanyaNew Drug Application2020-09-30
acnilunapproved drug other2024-05-30
adapalene 0.1% / benzoyl peroxide 2.5% / clindamycin 1%unapproved drug other2020-06-03
adapalene 0.3% / benzoyl peroxide 2.5% / clindamycin 1%unapproved drug other2020-06-03
benzaclinNew Drug Application2017-02-16
benzoyl peroxide 2.5% / clindamycin 1% / niacinamide 2% / tretinoin 0.025%unapproved drug other2019-05-22
benzoyl peroxide 2.5% / clindamycin 1% / niacinamide 4%unapproved drug other2019-04-23
benzoyl peroxide 2.5%, clindamycin phosphate 1%, niacinamide 2% / tretinoin 0.05%unapproved drug other2019-05-03
benzoyl peroxide 5% / clindamycin 1% / niacinamide 2% / spironolactone 2%unapproved drug other2019-05-10
benzoyl peroxide 5% / clindamycin 1% / niacinamide 2% / spironolactone 2% / tretinoin 0.025%unapproved drug other2019-05-03
Show 49 more
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
acne vulgarisEFO_0003894D000152L70
toxoplasmosisEFO_0007517D014123B58
bacterial infections—D001424A49
streptococcal infectionsEFO_1001476D013290—
bacterial vaginosisEFO_0003932D016585—
pneumocystis pneumoniaEFO_0007448D011020B59
staphylococcal infections—D013203A49.01
actinomycetales infectionsEFO_1001122D000193—
bacteroides infectionsEFO_1000832D001442—
rosacea—D012393L71
Show 3 more
Agency Specific
FDA
EMA
Expiration
Code
CLINDAMYCIN PHOSPHATE, XACIATO, ORGANON LLC
2029-12-07GAIN
2024-12-07NP
ADAPALENE / BENZOYL PEROXIDE / CLINDAMYCIN PHOSPHATE, CABTREO, BAUSCH
2026-10-20NP
BENZOYL PEROXIDE / CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE, TARO
2024-03-30PC
Patent Expiration
Patent
Expires
Flag
FDA Information
Adapalene / Benzoyl Peroxide / Clindamycin Phosphate, Cabtreo, Bausch
113894672040-12-28DPU-3713
82884342029-08-05DPU-124, U-134, U-818, U-916, U-921, U-1033, U-3713
95612082029-06-03DPU-916, U-3713
102200492029-06-03DPU-916, U-3713
106249182029-06-03U-916, U-3713
Clindamycin Phosphate, Xaciato, Organon Llc
111298962036-09-22U-3293
Benzoyl Peroxide / Clindamycin Phosphate, Acanya, Bausch
86636992029-06-03U-124
88950702029-06-03U-124
90788702029-06-03DP
95047042029-06-03DPU-124, U-134, U-818, U-916
101371422029-06-03DPU-916
Clindamycin Phosphate, Clindesse, Padagis Us
97890572026-12-02DPU-137
Clindamycin Phosphate, Evoclin, Mylan
71412372024-02-03DP
73747472024-01-23DPU-921
ATC Codes
D: Dermatologicals
— D10: Anti-acne preparations
— D10A: Anti-acne preparations for topical use
— D10AF: Antiinfectives for treatment of acne
— D10AF01: Clindamycin
— D10AF51: Clindamycin, combinations
G: Genito urinary system and sex hormones
— G01: Gynecological antiinfectives and antiseptics
— G01A: Antiinfectives and antiseptics, excl. combinations with corticosteroids
— G01AA: Antibiotics, gynecological
— G01AA10: Clindamycin
J: Antiinfectives for systemic use
— J01: Antibacterials for systemic use
— J01F: Macrolides, lincosamides and streptogramins
— J01FF: Lincosamides
— J01FF01: Clindamycin
HCPCS
Code
Description
S0077
Injection, clindamycin phosphate, 300 mg
Clinical
Clinical Trials
304 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Acne vulgarisD000152EFO_0003894L70——2114
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
InflammationD007249MP_0001845———1——1
Bacterial vaginosisD016585EFO_0003932———1——1
Vaginal diseasesD014623————1——1
Pruritus vulvaeD011539—L29.2——1——1
Vaginal dischargeD019522————1——1
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameClindamycin
INNclindamycin
Description
Clindamycin is a lincosamide antibiotic medication used for the treatment of a number of bacterial infections, including osteomyelitis (bone) or joint infections, pelvic inflammatory disease, strep throat, pneumonia, acute otitis media (middle ear infections), and endocarditis. It can also be used to treat acne, and some cases of methicillin-resistant Staphylococcus aureus (MRSA). In combination with quinine, it can be used to treat malaria. It is available by mouth, by injection into a vein, and as a cream or a gel to be applied to the skin or in the vagina.
Classification
Small molecule
Drug classantibiotics (Streptomyces strain)
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@H](C)Cl)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)N(C)C1
Identifiers
PDB—
CAS-ID18323-44-9
RxCUI—
ChEMBL IDCHEMBL1753
ChEBI ID—
PubChem CID446598
DrugBankDB01190
UNII ID3U02EL437C (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
Cleocin – Pfizer
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Estimated US medical usage
Clindamycin
+
Benzoyl peroxide
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Clindamycin
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Clindamycin
+
Tretinoin
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 42,339 documents
View more details
Safety
Black-box Warning
Black-box warning for: Cleocin hydrochloride, Cleocin pediatric, Cleocin phosphate, Cleocin phosphate cleocin phosphate (0009-6582) (standalone), Clindamycin, Clindamycin hcl, Clindamycin hydrochloride, Clindamycin hydrochloride clindamycin hydrochloride, Clindamycin in 5 percent dextrose, Clindamycin palmitate hydrochloride, Clindamycin palmitate hydrochloride (pediatric)
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
22,787 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use